Retroperitoneal ganglioneuroma is a completely mature, benign neurogenic tumor arising from the peripheral sympathetic nervous system. It represents the most benign end of the neuroblastic tumor maturation spectrum — the most mature form in the differentiation spectrum of neuroblastoma (malignant) → ganglioneuroblastoma (intermediate) → ganglioneuroma (benign). Typically seen between ages 10-40 with slight female predominance. It originates from the paravertebral sympathetic chain and locates in the posterior mediastinum or retroperitoneum. Most are asymptomatic and detected incidentally. On imaging, it appears as a well-defined, homogeneous, low-vascularity mass; markedly hyperintense signal on T2 and delayed enhancement pattern are characteristic. The tumor may grow encasing vessels without invasion. Risk of malignant transformation is negligible.
Age Range
5-40
Peak Age
20
Gender
Equal
Prevalence
Rare
Ganglioneuroma develops from neural crest-derived sympathoadrenal cells. These cells migrate from the neural crest during embryonic development to form sympathetic ganglia. Ganglioneuroma is the fully matured final form of neuroblastoma — in this process malignant neuroblasts differentiate into mature ganglion cells and Schwann cells proliferate to form stroma. Histologically, it contains mature ganglion cells and Schwann cells; no immature neuroblastic component is present. The myxoid stroma formed by Schwann cells provides marked T2 hyperintensity due to high water content — free water molecules have long T2 relaxation time in loose extracellular matrix. The fibrous stroma is responsible for delayed enhancement — contrast slowly diffuses into the fibrous interstitium and low capillary density results in minimal arterial phase enhancement. Low vascularity results from the mature Schwann cell stroma containing few vessels. The tumor may extend into the intervertebral foramen creating a dumbbell shape — a pathognomonic finding for neurogenic origin and critically important for surgical planning.
On T2-weighted MRI, a whorled pattern of hypointense fibrous bands within hyperintense myxoid stroma combined with delayed enhancement is the most characteristic finding combination for ganglioneuroma — reflecting alternating arrangement of Schwann cell stroma and fibrous bands, and the combination of high T2 + delayed enhancement is highly specific for differentiation from other retroperitoneal tumors.
On T2-weighted MRI, ganglioneuroma demonstrates markedly homogeneous hyperintense signal. Rarely, T2 hypointense fibrous bands may create a 'whorled appearance' within the tumor. Cystic or necrotic areas are not expected. This high signal reflects myxoid Schwann cell stroma and ganglioneuroma is one of the retroperitoneal tumors showing the highest T2 signal.
Report Sentence
The mass demonstrates markedly homogeneous hyperintense signal on T2 consistent with myxoid stroma; ganglioneuroma should be considered.
On contrast-enhanced CT, minimal enhancement in arterial phase with progressive mild enhancement in delayed phase (3-5 min). This delayed filling pattern is quite characteristic of ganglioneuroma and valuable for differentiation from other retroperitoneal tumors. Enhancement is homogeneous without necrotic or hypervascular foci. Enhancement is usually mild in portal venous phase and becomes more prominent in delayed phase.
Report Sentence
The mass shows no arterial enhancement but demonstrates progressive mild enhancement in the delayed phase; delayed filling pattern consistent with ganglioneuroma.
On non-contrast CT, a well-defined, homogeneous, low-density (20-40 HU) paravertebral mass is seen. Oval or fusiform shape. Calcification is rare and fine punctate — coarse calcification is seen in neuroblastoma and reflects maturation degree. Necrosis or hemorrhage not expected. Tumor may grow encasing vessels without invasion — reflecting its soft, deformable nature.
Report Sentence
A well-defined, homogeneous, low-density mass is seen in the retroperitoneal/paravertebral area; no necrosis or coarse calcification observed.
On DWI, ganglioneuroma does not show diffusion restriction. ADC values are high (1.5-2.5 × 10⁻³ mm²/s) — reflecting low cellular density and extensive extracellular matrix. This finding is the most valuable quantitative MR parameter for differentiating from malignant neurogenic tumors (neuroblastoma: ADC 0.6-1.0, MPNST: ADC 0.6-1.0). ADC value provides 85-90% accuracy in benign-malignant differentiation.
Report Sentence
No diffusion restriction is seen in the mass; high ADC values are consistent with benign neurogenic tumor.
Ganglioneuroma may extend into the intervertebral foramen creating a dumbbell shape — pathognomonic finding for neurogenic origin. Intraspinal extension into the spinal canal should be evaluated because spinal cord compression determines surgical indication. Bone erosion of vertebral body or foraminal widening may be seen — this is chronic pressure erosion and not malignant invasion. Foraminal widening has smooth margins.
Report Sentence
The mass extends intraspinally through the intervertebral foramen showing dumbbell configuration consistent with neurogenic origin.
On T1-weighted images, ganglioneuroma shows isointense to slightly hypointense signal relative to muscle. Homogeneous low-to-intermediate signal is seen throughout the entire mass. No hyperintense foci expected as it does not contain fat or methemoglobin. Non-contrast T1 images are fundamental for evaluating tumor margins and relationship with surrounding structures.
Report Sentence
The mass shows homogeneous isointense signal to muscle on T1.
Criteria
Completely mature ganglion cells and Schwann cells, no neuroblastic component, no mitotic activity
Distinct Features
Most common type (>80%), homogeneous imaging, no risk of malignant transformation, no recurrence expected after surgery
Criteria
Ganglioneuroblastoma in maturation process, >95% mature component, minimal immature foci
Distinct Features
Slightly heterogeneous imaging, minimal immature foci, follow-up needed — small areas of heterogeneity may be seen on MRI, spontaneous maturation may continue
Criteria
Associated with MEN2B or NF1, diffuse involvement of bowel wall or retroperitoneum, syndromic context
Distinct Features
Diffuse thickening rather than focal mass, plexiform pattern, syndromic association — medullary thyroid carcinoma and mucosal neuromas accompany in MEN2B
Distinguishing Feature
Neurofibroma shows target sign (central low signal, peripheral high signal on T2); ganglioneuroma lacks target sign and shows dominant homogeneous hyperintense T2 — both tumors are neurogenic but histologically distinct
Distinguishing Feature
MPNST shows heterogeneous T2, necrosis, rapid growth and diffusion restriction (ADC 0.6-1.0); ganglioneuroma shows homogeneous T2, slow growth and no diffusion restriction (ADC 1.5-2.5)
Distinguishing Feature
SFT shows low T2 signal (collagen) and intense early enhancement (hypervascular); ganglioneuroma shows high T2 signal (myxoid) and delayed enhancement — exactly opposite MR profile
Distinguishing Feature
Lymphoma usually shows multiple nodules and sandwich sign; ganglioneuroma is solitary, paravertebral with possible foraminal extension — lymphoma homogeneous intermediate T2, ganglioneuroma homogeneous high T2
Urgency
routineManagement
conservativeBiopsy
Not NeededFollow-up
12-monthGanglioneuroma is a benign tumor with practically no risk of malignant transformation. Small (<4 cm), asymptomatic lesions can be followed with annual MRI — follow-up interval may be extended once size stability is confirmed for 2-3 years. Surgery is recommended for symptomatic (pain, neurological deficit, compression) or large tumors and is curative — no recurrence expected after complete resection. If intraspinal extension (dumbbell tumor) is present, neurosurgical evaluation is needed and combined approach (anterior + posterior) may be planned. NF1 or MEN2B association should be evaluated — in syndromic context, diffuse ganglioneuromatosis possibility should be considered and additional screening performed. Preoperative biopsy is usually unnecessary because imaging findings provide high diagnostic confidence; however, in atypical findings (heterogeneity, rapid growth), malignant neurogenic tumor should be excluded.
Ganglioneuroma is a benign tumor and complete surgical resection is curative. Unlike neuroblastoma, it has no malignant potential. It may secrete catecholamines but is usually clinically silent. Urinary VMA/HVA levels may be elevated.